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Contemporary fetal growth standards are created by using theoretical properties (percentiles) of birth weight (for
gestational age) distributions. The authors used a clinically relevant, outcome-based methodology to determine if
separate fetal growth standards are required for singletons and twins. All singleton and twin livebirths between 36
and 42 weeks’ gestation in the United States (1995–2002) were included, after exclusions for missing information
and other factors (n ¼ 17,811,922). A birth weight range was identiﬁed, at each gestational age, over which serious
neonatal morbidity and neonatal mortality rates were lowest. Among singleton males at 40 weeks, serious neonatal
morbidity/mortality rates were lowest between 3,012 g (95% conﬁdence interval (CI): 3,008, 3,018) and 3,978 g
(95% CI: 3,976, 3,980). The low end of this optimal birth weight range for females was 37 g (95% CI: 21, 53) less.
The low optimal birth weight was 152 g (95% CI: 121, 183) less for twins compared with singletons. No differences
were observed in low optimal birth weight by period (1999–2002 vs. 1995–1998), but small differences were
observed for maternal education, race, parity, age, and smoking status. Patterns of birth weight-speciﬁc serious
neonatal morbidity/neonatal mortality support the need for plurality-speciﬁc fetal growth standards.
birth weight; fetal development; gestational age; infant mortality; morbidity
Abbreviation: CI, conﬁdence interval.
Traditional fetal growth standards, also called neonatal
anthropometric charts, are based on the birth weight distri-
bution of livebirths at each gestational age (1, 2). Ultraso-
nographic fetal growth standards, on the other hand, are
based on estimates of fetal weight obtained through a longi-
tudinal follow-up of healthy fetuses (3, 4). Both methods
havewell-recognized disadvantages; traditional fetal growth
standards use cross-sectional information from liveborn in-
fants to model longitudinal growth in utero (5), while ultra-
sonographic measurements suffer from an inability to
accurately estimate fetal weight (6).
Perhaps the most important deﬁciency common to both
methods arises because cutoffs for abnormal fetal growth
are determined by using statistical features of the weight
distribution (e.g., the 3rd or 10th percentile). This reliance
on theoretical aspects of weight distributions (without suf-
ﬁcient empirical support) is responsible for various prob-
lems including a lack of consensus in the current literature
with regard to normative values of birth weight for gesta-
tional age in several situations. For example, some fetal
growth standards are customized for maternal race (2, 7–
10), parity (4, 7, 8, 10–13), plurality (14, 15), height (4, 13),
weight (4, 13), and other characteristics, while others are not
(16, 17). In fact, some fetal growthstandards simultaneously
customize their cutoffs on the basis of a multitude of criteria
(8, 18). Although proponents of such standards, created by
using percentile-based methods, provide post hoc evidence
for customization (by demonstrating appropriate perinatal
mortality differences (19–21)), this justiﬁcation has been
disputed (22, 23).
Contemporary fetal growth standards are also responsible
for other unexpected inconsistencies. Neonatal mortality
rate differentials (mortality odds ratios) between small for
gestational age infants (at the 3rd or 10th percentile) and
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45th and 55th percentiles) vary substantially by gestational
age (24, 25). In addition, fetal and neonatal mortality rates
are higher among some ‘‘appropriate’’ birth weight for ges-
tational age subsets of births (e.g., those between the 10th
and 25th percentiles) as compared with some ‘‘abnormal’’
birth weight for gestational age subsets of births (e.g., those
above the 90th percentile) (26).
Because the utility of fetal growth standards is dependent
on their ability to identify subpopulations at higher risk for
perinatal mortality and serious neonatal morbidity, we pro-
posed that patterns of serious neonatal morbidity and neo-
natal mortality should directly guide the creation of fetal
growth standards. In this paper, we used this alternative,
clinically relevant, outcome-based method for creating fetal
growth standards to answer a speciﬁc question: Do single-
tons and twins require separate fetal growth standards?
MATERIALS AND METHODS
Data were obtained from the perinatal mortality data ﬁles
of the National Center for Health Statistics for the years
1995–2002. All singleton and twin livebirths with a clinical
estimate of gestation between 36 and 42 weeks born towhite
or black mothers resident in the United States were included
in the study. The exclusion criteria included livebirths with
the following attributes: 1) with unknown sex, birth weight,
or gestational age; 2) with improbable combinations of birth
weight for gestational age (16); 3) with congenital anoma-
lies or those from a state that did not report congenital
anomalies; 4) with an ending in neonatal death due to
homicide or accident; and 5) with missing information
on serious neonatal morbidity. The data set included
32,428,118 livebirths and, after exclusions, 17,811,922
livebirths were available for analysis (a substantial fraction
of the data was excluded because California did not report
the clinical estimate of gestational age). The same exclu-
sion criteria were applied for both singletons and twins.
Because it was not possible to identify twin pairs in the data
ﬁles, only twin infants affected by the above criteria were
excluded.
As per traditions in perinatology (27, 28), the primary
outcome of interest was deemed to be serious neonatal mor-
bidity or neonatal death (<28 days after birth). Serious neo-
natal morbidity included any of the following: 5-minute
Apgar score of <4, assisted ventilation for 30 minutes or
more, and neonatal seizures. Such perinatal events are very
strongly associated with death and serious disability in long-
term follow-up studies (29, 30). Gestational age was based
on the clinical estimate of gestation because it typically
avoids misclassiﬁcation errors and is more relevant to clin-
ical practice (31–33).
On the basis of empirical observation, we proposed that
birth weight-speciﬁc patterns of serious neonatal morbidity
or neonatal death at each gestational agewouldfollow a spe-
ciﬁc pattern, that is, that neonatal morbidity/mortality rates
decrease exponentially with increasing birth weight in the
low birth weight range (Figure 1, part A). This declining
pattern then changes to a ﬂat, stable rate at ‘‘optimal’’ birth
weight before serious neonatal morbidity/neonatal mortality
rates increase with increasing birth weight at very high birth
weights. We, therefore, categorized the birth weight range at
each gestational age by estimating 3 cutpoints, namely, 1)
the birth weight at which the probability of serious neonatal
morbidity/neonatal mortality changed from 1 (i.e., no sur-
vival) to less than 1 (viability weight); 2) the birth weight at
which the inverse relation between birth weight and serious
neonatal morbidity/neonatal mortality changed to a ﬂat re-
lation (i.e., the lower bound of optimal birth weight (labeled
low optimal weight)); 3) the birth weight at which the ﬂat
relationbetween birth weightand serious neonatalmorbidity/
neonatal mortality changed to a positive relation (i.e., the
upper bound of optimal birth weight (labeled high optimal
weight)). We also estimated 2 slopes, namely, 1) the inverse
relationbetween birth weightand serious neonatalmorbidity/
neonatal mortality over a restricted birth weight range (slope
B1); and 2) the positive relation between birth weight and
seriousneonatalmorbidity/neonatalmortalityoverarestricted
birth weight range (slope B2).
The estimation of cutpoints and slope parameters was
carried out by maximum likelihood methods, by using non-
linear minimization of the appropriate binomial  2 log
likelihood. This procedure involvedestimation of the above-
mentioned 5 parameters that deﬁne the piecewise linear
model for the log probability of serious neonatal morbidity
or neonatal death at a particular gestational age. We incor-
porated additional parameters in order to allow the model
parameters to vary by week of gestation. We also incorpo-
rated simple constraints to ensure that the viability weight
was nonnegative, the viability weight at any gestation was
lower than the low optimal weight at that gestation, the
slope B1 was negative, and the slope B2 was positive;
95% conﬁdence intervals based on the asymptotic distribu-
tion were estimated around these birth weights.
The primary determinant included in the model was plu-
rality (twins vs. singletons), and the parameters of primary
interest were the lower bound of the optimal birth weight
range for singletons and twins at each gestational period.
These cutpoints disregard the absolutevalues of serious neo-
natal morbidity/neonatal mortality among singletons and
twins and focus on the birth weight at which morbidity/
mortality reaches its nadir. Other determinants added to
the model included terms for infant’s sex (females vs.
males), period (1995–1998 vs. 1999–2002), maternal edu-
cational status (<12 years of schooling vs.  12 years), race
(black vs. white), age ( 35 vs. <35 years), parity (nullipa-
rous vs. parity  1), and smoking (yes vs. no). The a priori
expectation was that the low optimal birth weight would be
different across infants’sex categories but not across period.
We carried out supplementary analyses to assess the ef-
fects of potential inaccuracies in the perinatal mortality ﬁles
with regard to diagnoses of serious neonatal morbidity by
repeating the regression using neonatal mortality as the out-
come. In a second supplementary analysis, we used the
menstrual-based estimate of gestational age instead of the
clinical estimate.
Analysis was carried out by using the SAS nonlinear pro-
gramming procedure PROC NLP, version 9.1 (SAS Insti-
tute, Inc., Cary, North Carolina). The data were randomly
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were obtained by combining the 4 sets of results by using
weights based inversely on the variance of the estimates.
The study was approved by the Research Ethics Board of
the IWK Health Centre.
RESULTS
Of the 17,811,922 livebirths included in the study,
17,554,934 were singletons and 256,988 (1.4%) were twins.
The overall frequency of neonatal death was 0.57 per 1,000
livebirths, while the frequency of serious neonatal morbidity
was 5.4per1,000livebirths(Apgar score of<4at5minutes,
1.1 per 1,000; assisted ventilation for  30 minutes, 3.6 per
1,000; and neonatal seizures, 0.6 per 1,000 livebirths). The
neonatal death rate was 0.56 per 1,000 livebirths among
singletons and 0.95 per 1,000 livebirths among twins; the
rate of serious neonatal morbidity was 5.3 and 11.3 per
1,000 livebirths among singletons and twins, respectively.
Figure 1, part B, shows the patterns of serious neonatal
morbidity/mortality among singletons versus twins at 37
weeks’ gestation, with rates calculated within arbitrary
100-g categories of birth weight (1,000–1,099 g, 1,100–
1,199 g, etc.). Although the absolute rates of serious neo-
natal morbidity/mortality were similar at most birth
weights, there were few outcome events at higher birth
weights among twins, and visual inspection suggested that
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Figure 1. Birth weight-speciﬁc rates of serious neonatal morbidity and neonatal mortality at 37 weeks’ gestational age among singletons (part A)
and among singletons and twins (part B), United States, 1995–2002.
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cutoffs. Table 1 provides the point estimates for the low and
high optimal birth weights for female and male singleton
livebirths from the regression model. The low optimal birth
weight at 40 weeks’ gestation was 2,982 g (95% conﬁdence
interval (CI): 2,965, 2,999) for females and 3,012 g (95%
CI: 3,008, 3,018) for males. Similarly, the birth weight cut-
off at the high end of the optimal birth weight range was
3,813 g (95% CI: 3,774, 3,852) for females and 3,978 g
(95% CI: 3,976, 3,980) for males. The average low optimal
birth weight cutoff for females was 37 g (95% CI: 21, 53)
less than the same value for males, while the average high
optimal birth weight cutoff for females was 206 g (95% CI:
168, 244) less. The low optimal birth weight cutoffs were
generally close to the 10th percentile, and the high optimal
birth weight cutoffs were generally close to the 90th percen-
tile of birth weight for gestational age. However, the 10th
percentile values were lower than the low optimal birth
weight and outside the 95% conﬁdence interval for several
of the gestational weeks among females (Figure 2). Among
the males, on the other hand, the 10th percentile values were
higher than the low optimal birth weight and outside the
95% conﬁdence interval for several of the gestational weeks
(Figure 3). The low optimal birth weight cutoff estimates
were reasonably precise, except at 36 and 42 weeks’ gesta-
tion, while the high optimal birth weight estimates were
much less precise.
Table 2 shows the same low and high optimal birth weight
estimates for twin livebirths. On average, the low optimal
birth weight estimate was 152 g (95% CI: 121, 183) less for
twins compared with singletons, and the high optimal
weight was 402 g (95% CI: 94, 710) more for twins com-
pared with singletons. The low optimal birth weights for
twins were substantially higher than the 10th percentile birth
weight for gestational age estimates among both male and
female twins, and the high optimal birth weight estimates
were substantially higher than the 97th percentile, although
these latter estimates had wide conﬁdence limits.
Table 3 shows the results of the regression model for low
and high optimal birth weight. The low and high optimal
birth weights were 3,012 g and 3,978 g for the referent
group (singletons at 40 weeks’ gestation). The period
(1999–2002 vs. 1995–1998) did not change the low optimal
birth weight. Education for <12 years and smoking reduced
the low optimal birth weight signiﬁcantly, while nulliparity,
African-American race, and advanced maternal age in-
creased the low optimal birth weight estimate. The magni-
tude of these effects was small, being approximately the
same or lesser than the effect of gender.
Supplementary analyses showed that serious neonatal
morbidity was strongly associated with neonatal and post-
neonatal mortality (neonatal mortality rates were 32.9 and
0.41 per 1,000 livebirths, respectively, and postneonatal
mortality rates were 8.0 and 1.4 per 1,000 neonatal survi-
vors, respectively, among those with and those without se-
rious neonatal morbidity). Analyses with neonatal mortality
as the outcome showed a  345 g difference in low optimal
birth weight between singletons and twins (Table 4). How-
ever, the difference in low optimal birth weight for single-
tons between the 2 models (3,012 vs. 3,244 g among males
at 40 weeks) meant that the low optimal birth weight for
twins was similar between the 2 models (2,860 vs. 2,899 g
among males at 40 weeks). Differences in low optimal birth
weight were observed for other gestational weeks, parity,
Table1. Estimates of the Lowand High Optimal BirthWeightand Percentiles of theBirth WeightDistribution at 36–
42 Weeks’ Gestational Age Among Female and Male Singleton Livebirths, United States, 1995–2002
Gestational
Age, weeks
Low Optimal Birth Weight, g High Optimal Birth Weight, g Birth Weight, g, by Percentile
Estimate
95%
Conﬁdence
Interval
Estimate
95%
Conﬁdence
Interval
3 1 09 09 7
Females
36 2,260 2,231, 2,289 3,801 3,585, 4,017 1,985 2,255 3,345 3,714
37 2,482 2,458, 2,506 3,564 3,502, 3,608 2,211 2,466 3,572 3,912
38 2,753 2,731, 2,775 3,736 3,661, 3,811 2,438 2,665 3,771 4,082
39 2,875 2,851, 2,899 3,819 3,767, 3,871 2,595 2,835 3,912 4,196
40 2,982 2,965, 2,999 3,813 3,774, 3,852 2,693 2,930 4,025 4,309
41 3,091 3,069, 3,113 3,923 3,876, 3,970 2,807 3,040 4,139 4,423
42 3,030 2,942, 3,118 4,114 3,667, 4,561 2,807 3,062 4,224 4,536
Males
36 2,296 2,268, 2,324 4,013 3,794, 4,232 2,070 2,353 3,463 3,830
37 2,516 2,495, 2,537 3,777 3,710, 3,844 2,296 2,570 3,714 4,054
38 2,785 2,763, 2,807 3,912 3,833, 3,991 2,523 2,778 3,912 4,232
39 2,912 2,888, 2,936 3,997 3,944, 4,050 2,693 2,948 4,054 4,366
40 3,012 3,008, 3,018 3,978 3,976, 3,980 2,778 3,033 4,167 4,479
41 3,129 3,106, 3,152 4,088 4,016, 4,160 2,898 3,175 4,309 4,593
42 3,071 2,983, 3,159 4,313 3,860, 4,766 2,920 3,202 4,394 4,706
Outcome-based Fetal Growth Standards 619
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not be determined because of problems estimating the co-
variance matrix. Similar results were obtained with regard to
the high end of optimal birth weight and from the model by
using gestational age based on menstrual dates (low optimal
birth weight for singletons ¼ 3,051 g) (difference between
singletons and twins ¼ 391 g, 95% CI: 428, 354).
DISCUSSION
Our study showed that patterns of birth weight-speciﬁc
serious neonatal morbidity and neonatal mortality identify
a low end of the optimal birth weight for gestational age
range that differs among singletons and twins between 36
and 42 weeks’ gestation. This difference was substantial,
being 152 g (95% CI: 121, 183), in comparison with
a smaller difference of 37 g (95% CI: 21, 53) between male
and female livebirths. The ﬁnding that the low optimal birth
weight cutoff was lower for twins than for singletons has
important clinical implications, especially from the stand-
point of obstetric intervention. Although the estimated fetal
weight for gestational age is but one of several different
inputs into the decision regarding obstetric intervention, this
empirical justiﬁcation for separate cutoffs for singletons and
twins provides an additional rationale for more careful fetal
monitoring in multifetal pregnancy.
Standards of birth weight for gestational age are typically
used for 3 purposes: 1) obstetric identiﬁcation of abnormal
fetal growth (with medically indicated early delivery an
option, given seriously compromised growth); 2) neonatal
identiﬁcation of growth-restricted newborns (for growth
monitoring and nutritional supplementation); and 3) identi-
ﬁcation of populations with high rates of fetal growth
restriction for public health surveillance and as a focus
for intervention. Creating a standard for this third purpose
probably represents the least challenging task, as identify-
ing regional variations, temporal trends, or high-risk sub-
populations can be accomplished with an arbitrary but
constant standard. Creating standards for the ﬁrst 2 clinical
uses, however, requires an outcome-based, clinically rele-
vant criterion that statistical percentiles of birth weight for
gestational age fail to provide. Our alternative method-
ology attempted to directly address the neonatal need for
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Figure 2. Estimates and 95% conﬁdence intervals for the low opti-
mal birth weight and the 10th percentile of birth weight for gestational
age (part A) and the high optimal birth weight and the 97th percentile
of birth weight for gestational age (part B) among female singletons
and female twins, United States, 1995–2002.
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Figure 3. Estimates and 95% conﬁdence intervals for the low opti-
mal birth weight and the 10th percentile of birth weight for gestational
age (part A) and the high optimal birth weight and the 97th percentile
of birth weight for gestational age (part B) among male singletons and
male twins, United States, 1995–2002.
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natal morbidity/mortality rates are higher outside the birth
weight range identiﬁed by the low and high optimal birth
weight cutoffs. In an indirect sense, these cutoffs also pro-
vide birth weight for gestational age information for the
obstetric identiﬁcation of growth-restricted fetuses, since
neonatal morbidity/mortality patterns are a reﬂection of fe-
tal health and well-being. However, the absolute values of
optimal birth weight for gestational age are of little obstetric
use, because estimation of fetal weight is currently inaccu-
rate and obstetricians increasingly rely on other measures
of compromised fetal growth, such as umbilical artery
systolic/diastolic ratios (34). From an obstetric perspective,
therefore, the primary ﬁnding of our study relates to the
Table 2. Point Estimates of the Low and High Optimal Birth Weight and Percentiles of the Birth Weight Distribution
at 36–40 Weeks’ Gestational Age Among Female and Male Twin Livebirths, United States, 1995–2002
Gestational
Age, weeks
Low Optimal Weight, g High Optimal Weight, g Birth Weight, g, by Percentile
Estimate
95%
Conﬁdence
Interval
Estimate
95%
Conﬁdence
Interval
31 0 9 0 9 7
Females
36 2,106 2,069, 2,143 4,248 3,906, 4,590 1,814 2,040 2,920 3,147
37 2,331 2,293, 2,369 4,151 3,884, 4,418 1,956 2,183 3,085 3,323
38 2,592 2,555, 2,629 4,193 3,897, 4,489 2,070 2,296 3,232 3,470
39 2,724 2,689, 2,759 4,327 4,029, 4,625 2,126 2,353 3,290 3,544
40 2,822 2,788, 2,856 4,230 3,911, 4,549 2,126 2,325 3,345 3,629
Males
36 2,139 2,101, 2,177 4,445 4,098, 4,792 1,899 2,126 3,033 3,278
37 2,365 2,327, 2,403 4,353 4,093, 4,613 2,041 2,268 3,204 3,459
38 2,625 2,587, 2,663 4,392 4,102, 4,682 2,135 2,381 3,350 3,615
39 2,756 2,718, 2,794 4,529 4,237, 4,821 2,183 2,448 3,459 3,725
40 2,854 2,820, 2,888 4,427 4,119, 4,735 2,211 2,466 3,487 3,799
Table 3. Results of Regression Modeling of Birth Weight-speciﬁc Serious Neonatal Morbidity and Neonatal
Mortality Rates Showing Estimates of Low and High Optimal Birth Weight by Infant and Maternal Characteristics,
United States, 1995–2002
Determinant
Low Optimal Weight, g
P Value
High Optimal Weight, g
P Value
Estimate
95%
Conﬁdence
Interval
Estimate
95%
Conﬁdence
Interval
40 weeks (referent
a) 3,012 3,007, 3,017 3,978 3,976, 3,980
36 weeks  724  752,  696 <0.001 7  212, 226 0.95
37 weeks  491  513,  469 <0.001  148  216,  80 <0.001
38 weeks  247  271,  223 <0.001  53  132, 26 0.19
39 weeks  107  131,  83 <0.001 35  18, 88 0.20
41 weeks 99 76, 122 <0.001 140 68, 212 <0.001
42 weeks 42  45, 129 0.35 335  118, 788 0.15
Female sex  37  53,  21 <0.001  206  244,  168 <0.001
Twins  152  183,  121 <0.001 402 94, 710 0.01
Period, 1995–1998 1  12, 14 0.86 47  3, 97 0.07
Education <12 years  42  58,  26 <0.001  106  170,  42 0.001
Nulliparous 31 18, 44 <0.001 328 255, 402 <0.001
African American 23 8, 38 0.003  347  384,  310 <0.001
Smoker  42  58,  26 <0.001  310  407,  213 <0.001
Age  35 years 26 6, 46 0.009  54  135, 27 0.19
a Referent estimates apply to infants at 40 weeks who are male, singletons, born between 1999 and 2002, with
maternal education  12 years, parity  1, white race, nonsmoking status, and <35 years of age.
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tational age between singletons and twins. This implies
a lower birth weight for gestational age threshold for med-
ically indicated intervention among twins relative to single-
tons. The low optimal birth weight for twins identiﬁed in our
study was between the 10th percentile of birth weight for
gestation for singletons and the 10th percentile of birth
weight for gestational age for twins (Figures 2 and 3).
The small difference in the low and high optimal birth
weight cutoffs for males and females seen in our study was
in line with a priori expectations. The lack of an effect with
regard to calendar period was also expected; the pattern of
birth weight-speciﬁc neonatal morbidity/mortality (at
a given gestation) is not likely to be affected by secular
increases in birth weight for gestational age (35, 36). The
differences noted in the optimal birth weight range with
regard to African Americans were unexpected. Previous
studies have shown that available customized fetal growth
standards for whites and African Americans (10) are not
consistent with observed patterns of perinatal mortality seen
under the fetuses at risk formulation (37, 38). In addition,
the racial differences in low optimal birth weight found in
this study were small at 23 g (95% CI: 8, 38). Because such
small differences may not be clinically relevant and possibly
also confounded by uncontrolled factors, we do not believe
that this study supports separate fetal growth standards by
race, educational status, parity, smoking, and maternal age.
The approximate concordance between the low optimal
birth weight and the 10th percentile of birth weight for
gestational age among singletons merits further comment.
Pediatric weight-for-age standards, created on the basis of
the weights of normal children (39), have used the third
percentile (or the equivalent mean minus 2 standard devia-
tions) for identifying growth faltering (analogous to the use
of a P value cutoff of 5% for statistical signiﬁcance under
the null hypothesis). Fetal growth standards, on the other
hand, have tended to use the 10th percentile of birth weight
for gestational age as a cutoff for identifying growth-
restricted fetuses/infants. The higher percentile cutoff for
fetal growth standards (typically created by using vital sta-
tistics data) was intended to account for the mixed normal
and abnormal population (i.e., fetuses from complicated and
uncomplicated pregnancies) used in standard creation. The
approximate concordance between our low optimal birth
weight cutoffs and the 10th percentile among singletons is
a testament to the general validity of this logic.
The strengths of our study include a methodology that is
outcome based and clinically relevant. Moreover, the cutoffs
identiﬁed were based on the clinical estimate of gestation;
this estimate is free from the errors typically present in
menstrual-based estimates (31–33) and increases the clini-
cal utility of our ﬁndings. The general congruence between
the model with neonatal morbidity/mortality versus the
model with neonatal mortality also lends support to our in-
ference; gestational age-speciﬁc patterns of serious neonatal
morbidity are approximately similar to neonatal mortality
(40). The large numbers of subjects in the study, despite the
exclusion of livebirths likely to negatively affect study re-
sults (including those with imputed birth weight, congenital
anomalies, etc.), also represent a strength.
The limitations of the study include the data quality
weaknesses inherent in large perinatal databases. We ex-
cluded stillbirths because their estimates of birth weight
and gestational age (at death) are known to be inaccurate
(41, 42). A gestational age restriction (36–42 weeks) was
required because the number of livebirths aged <36 weeks
was relatively small. Our ﬁndings are probably generaliz-
able to gestations below 36 weeks, although further work is
required to determine optimal birth weights at early gesta-
tion. The truncation of the lifecourse in our model (which
used livebirths rather than fetuses at risk) may have causal
implications (24, 43), even if our comparisons were within
determinant categories; for example, the optimal low birth
weight for twins was based on patterns of morbidity/
mortality among twins. Livebirths in our study represent
fetuses who did not deliver before 36 weeks’ gestation.
Because the rates of spontaneous and iatrogenic delivery
prior to 36 weeks are higher among twins than among single-
tons, singleton fetuses surviving to 36 weeks are likely dif-
ferent from twins surviving to 36 weeks (especially at both
extremes of birth weight). Thus, birth weight for gestational
age is probably better viewed as a noncausal predictor of
serious neonatal morbidity/mortality (along with other prog-
nostic indicators). The relatively wide conﬁdence intervals
and some inconsistent estimates of the high optimal birth
weight among twins show that this analytical method is
sensitive to a paucity of outcome events. Gestational age
Table 4. Resultsof Supplementary AnalysesShowing Estimates of
Low Optimal Weight From a Model Based on Neonatal Mortality,
United States, 1995–2002
Determinant
Low Optimal Birth Weight, g
P Value
Estimate
95%
Conﬁdence
Interval
40 weeks (referent
a) 3,244 —
b
36 weeks  464 — —
37 weeks  284  324,  244 <0.001
38 weeks  172  220,  124 <0.001
39 weeks  4  49, 41 0.86
41 weeks 140 85, 195 <0.001
42 weeks 246 77, 415 0.004
Female sex  121 — —
Twins  345  406,  284 <0.001
Period, 1995–1998 17 — —
Education <12 years  60  93,  27 <0.001
Nulliparous 127 92, 162 <0.001
African American  185  227,  143 <0.001
Smoker  244  298,  190 <0.001
Age  35 years 20  25, 65 0.12
a Referent estimates apply to infants at 40 weeks who are male,
singletons, born between 1999 and 2002, with maternal education
 12 years, parity  1, white race, nonsmoking status, and <35 years
of age.
b —, could not be determined because of problems in estimation of
the covariance matrix.
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36-week infants) is another plausible explanation for incon-
sistentpatterns,andthe higherlikelihoodofcesareandelivery
for larger twins may, in part, explain the infrequent adverse
outcomes at high birth weight. Other limitations included
potential inaccuracies in the reporting of serious neonatal
morbidity (although such errors would not affect our results
unless they were differential by gestational age or birth
weight) and our inability to treat twins pairs as non-
independent observations (although analyses with Nova
Scotia data suggest that this limitation would have had a rel-
atively modest effect on the precision of the estimates in this
study). Our analyses also did not incorporate various risk
factors, such as birth weight discordance, and we did not
use smoothing procedures.
In conclusion, we have proposed a clinically relevant,
outcome-based method for developing fetal growth stand-
ards that identiﬁes optimal birth weight for gestational age
based on patterns of serious neonatal morbidity and neonatal
mortality. Substantial differences were noted at the low and
high ends of the optimal birth weight range for singletons
and twins. Speciﬁcally, the low optimal birth weight cutoffs
at each gestation (between 36 and 40 weeks), at which the
rates of serious neonatal morbidity and neonatal mortality
increase,are lowerfor twins than forsingletons. This ﬁnding
has clinical implications and identiﬁes the need for different
thresholds for both obstetric intervention among singleton
and twin fetuses and for growth monitoring and nutritional
supplementation among singleton and twin infants.
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